Plasma concentration — effect relationships for felodipine: A meta analysis
暂无分享,去创建一个
T. Hedner | B. Edgar | D. Elmfeldt | T Hedner | E Blychert | B Edgar | D Elmfeldt | E. Blychert | Eva Blychert | Dag Elmfeldt
[1] C. Regårdh,et al. Pharmacokinetics of felodipine in patients with impaired renal function. , 1989, British journal of clinical pharmacology.
[2] B. Folkow. Physiological aspects of primary hypertension. , 1982, Physiological reviews.
[3] C. Regårdh,et al. Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.
[4] T. Hedner,et al. Plasma Concentration—Effect Relationships of Intravenous and Extended‐Release Oral Felodipine in Hypertensive Patients , 1990, Journal of cardiovascular pharmacology.
[5] F. Bühler,et al. The place of the calcium antagonist verapamil in antihypertensive therapy. , 1982, Journal of cardiovascular pharmacology.
[6] G. Nyberg. Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (auto-manometer)--response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade. , 1977, British journal of clinical pharmacology.
[7] T. Hedner,et al. A population study of the pharmacokinetics of felodipine. , 1991, British journal of clinical pharmacology.
[8] T. Hedner,et al. Antihypertensive effects and pharmacokinetics of felodipine combined with a beta-blocker and a diuretic. , 1987, Journal of cardiovascular pharmacology.
[9] C. Regårdh,et al. Clinical pharmacokinetics of felodipine. A summary. , 1987, Drugs.
[10] D. Beevers,et al. RELATION BETWEEN INITIAL BLOOD PRESSURE AND ITS FALL WITH TREATMENT , 1985, The Lancet.
[11] L. Sheiner,et al. Study designs for dose‐ranging , 1989, Clinical pharmacology and therapeutics.
[12] P. Meredith,et al. Initial blood pressure as a predictor of the response to antihypertensive therapy. , 1988, British journal of clinical pharmacology.
[13] P. Erne,et al. Calcium antagonism--a new concept for treating essential hypertension. , 1986, The American journal of cardiology.
[14] R. N. Brogden,et al. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. , 1985, Drugs.
[15] M. Ahnoff. Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. , 1984, Journal of pharmaceutical and biomedical analysis.
[16] C. Regårdh,et al. Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.
[17] D. Abernethy. Amlodipine: pharmacokinetic profile of a low-clearance calcium antagonist. , 1991, Journal of cardiovascular pharmacology.
[18] D. Breimer,et al. Nifedipine: Kinetics and dynamics in healthy subjects , 1984, Clinical pharmacology and therapeutics.
[19] J. Newburger,et al. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. , 1982, American heart journal.
[20] M. Ahnoff,et al. Comparison of high-selectivity gas chromatographic methods, including column switching, for the determination of felodipine in plasma. , 1987, Journal of chromatography.